Lab Innovations Signs Partnership with One Nucleus
News Sep 06, 2016
Lab Innovations, the UK’s only event dedicated to laboratory professionals, has signed a new partnership with One Nucleus. As part of the deal, One Nucleus members will be able to exhibit for a discounted rate at the show, which takes place on 2 & 3 November 2016 at the NEC, Birmingham.
Based in Cambridge, at the heart of Europe’s largest life science and healthcare cluster, One Nucleus is an international membership organisation for life science and healthcare companies. Collectively the One Nucleus membership forms a commercial, clinical and academic powerhouse of over 470 organisations. As a result, this partnership is expected to draw new communities to the show, in particular expanding the event’s reach to more pharmaceutical, biotech, medical device and diagnostic companies.
Once Nucleus joins a number of respected bodies already showing their support for the event. These include the Royal Society of Chemistry, GAMBICA, Campden BRI and The Science Council.
Katie Crocombe, Lab Innovations Event Director, adds: “It’s fantastic to bring One Nucleus on board and grow our support network. Not only does it deepen our links within the life science sector but it gives One Nucleus members, who exhibit, the opportunity to get themselves in front of thousands of buyers and decision makers from the industry. Similarly, members visiting the show will have access to a wealth of content and fantastic networking opportunities. One Nucleus’ involvement demonstrates how quickly Lab Innovations has grown as a hub for all of the UK’s lab community.”
At Lab Innovations 2016, laboratory professionals from a wide range of industry sectors will be given the opportunity to see the latest products and services on the market. Exhibitors include the industry’s most important suppliers and partners, key thought-leading trade, associations and professional bodies. Last year saw decision makers from big names such as Sainsbury’s, Kellogg’s, Rolls Royce and 3M walk the show floor. Visitors can also attend free educational seminars and network with their peers.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
This Seed Could Bring Clean Water to MillionsNews
Biomedical Engineering and Chemical Engineering Professors Bob Tilton and Todd Przybycien recently co-authored a paper with Ph.D. students Brittany Nordmark and Toni Bechtel, and alumnus John Riley, further refining a process that could soon help provide clean water to many in water-scarce regions. The process, created by Tilton’s former student and co-author Stephanie Velegol, uses sand and plant materials readily available in many developing nations to create a cheap and effective water filtration medium, termed “f-sand.”READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE